top of page

Sanofi says next-gen COVID booster shot has Potential Against Main Variants



French drugmaker Sanofi (SASY.PA) said on Monday an upgraded version of the COVID-19 vaccine candidate it is developing with GSK (GSK.L) showed potential in two trials to protect against the virus's main variants of concern, including the Omicron BA.1 and BA.2 strains, when used as a booster shot. That sounds great!



Photo Credit: Jeremy Bezanger

 
 
 

Comentarios


Thanks for submitting!

Stay updated on the latest good newz!

GoodNewzUniversal brings the top positive news about the world, daily. No matter what happens, there is always going to be good news all over the world. This website has assembled it, just for you.

    © 2023 BY ARYAMAN SINHA

    bottom of page